46th Annual Carrell Krusen Neuromuscular Symposium (RP2402A)

February 22, 2024 to February 23, 2024

Early-Bird Registration Now Open!

Registration TypeBefore 1/12/24After 1/12/24
Physicians (MD/DO)$250$300
Advanced Practice Providers (PAs/NPs)$250$300
Other Healthcare Professionals (OT/PT/SPL)$150$200
Trainees (Fellows/Residents/Medical Students)$75$100
Research Coordinators$75$100
Exhibit/Industry Representative$275$325

This symposium is a clinical education experience for members of multidisciplinary teams who care for patients with rare, complex neuromuscular diseases including hereditary muscular dystrophies, motor neuron diseases, neuroimmunologic neuropathies and rare genetic disorders of muscle and nerve. Case presentations will include physical diagnosis and discussion of management and new therapies by participating experts. All discussions involve active participation by attendees. The educational format for this activity includes didactic lectures with in depth Q&A, panel discussions, and PowerPoint Presentations. The content of the program is identified and developed through a Call for Abstracts process. The 2024 keynote speaker will present on the designing clinical trials and organizing clinical trial networks specifically in the area of Amyotrophic Lateral Sclerosis.

Help shape this year's conference by submitting an abstract! Open to all members of the interdisciplinary team. The deadline for abstract submission is Friday, December 1, 2023.

Target Audience

This course content is specifically designed for Primary Care providers, Neurologists, Nurses, Advanced Practitioners, and Researchers that desire to gain advanced knowledge in diagnosis and management of patients with neuromuscular disease.

Learning Objectives

  1. Discuss important aspects of ALS trial design
  2. Compare and contrast current and traditional strategies for ALS Drug development
  3. Discuss recent advances in the genetic diagnosis of neuromuscular disorders
  4. Discuss the latest developments in the treatment of neuromuscular disorders (to include gene replacement therapy).
  5. Identify and apply current pharmacological and non-pharmacological treatments in motor neuron diseases including gene replacement therapy.
  6. Recognize the clinical applications of testing in neuromuscular disorders (to include histopathology)
Course summary
Available credit: 
  • 10.50 AMA
  • 10.50 Attendance
Course opens: 
Course expires: 
Event starts: 
02/22/2024 - 8:00am CST
Event ends: 
02/23/2024 - 5:00pm CST
Hotel TBD
Dallas, TX
United States

More details regarding conference hotel coming soon! Please check back at a later date.

Peer reviewer(s)

Zurisadai Gonzalez Castillo

has no relevant financial relationships to disclose at this time.

Erica Knoll, MPAS, PA-C

has no relevant financial relationships to disclose at this time.

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Texas Southwestern Medical Center designates this live activity for a maximum of 10.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 10.50 AMA
  • 10.50 Attendance


Please login or create an account to take this course.


To register:

  1. "Login" to your existing account or create an account in EthosCE, online learning management system, by selecting the "create an account" link.
  2. Once logged in, return to this course page, select the designated fee and click the "add to cart" button.
  3. In the following "checkout" pages you will verify and process your payment.
  4. After registration is completed, a confirmation will be sent by email.

A $25 handling fee will be deducted from cancellation refunds. Refund requests must be received by email at cmeregistrations@utsouthwestern.edu by February 8, 2024.  No refunds will be made thereafter.